mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.4 |